相关实验视频
Updated: Jul 13, 2025

08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
7.2K
连接素在炎症性肠病发展中的生物功能
Qiaojing Yan1,2, Zhiling Feng1, Bin Jiang1,2
1Colorectal Surgery Center, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China.
Scandinavian journal of gastroenterology
|October 14, 2023
概括
连接素 (Cxs),特别是Cx43,在炎症性肠病 (IBD) 的发展中发挥着至关重要的作用,通过在肠道炎症期间调解细胞对细胞的通信. 了解Cx功能是IBD病变研究的关键.
科学领域:
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 炎症性肠病 (IBD) 包括慢性肠道炎症状况,主要原因不明.
- 由连接素 (Cxs) 形成的间隙结,越来越多地被认为是IBD病原体的重要贡献者.
- 这些结点连接信号通路,对于肠道炎症细胞相互作用至关重要.
研究的目的:
- 为了提供有关生物功能的全面叙事审查.
- 具体阐明Cx43的作用,最丰富的连素,在IBD的发病过程中.
- 为了将连素信号传递与IBD背后的炎症过程联系起来.
主要方法:
- 关于连接素和IBD的现有研究的文献综述.
- 对聚焦于肠道炎症背景下连接素的表达和功能的研究进行分析.
- 对Cx43参与炎症细胞相互作用和信号通路的数据的综合.
主要成果:
- 连接素,特别是Cx43,是IBD炎症反应的组成部分.
- 间隙结促进免疫细胞和肠上皮细胞之间的通信,推动疾病的进展.
- Cx43调节信号级联,使肠道炎症延续.
结论:
- 连接素是炎症性肠病的发展和进展的关键调解者.
- 准Cx43介导途径可能为IBD提供新的治疗策略.
- 对连素生物学进行进一步的研究对于理解和治疗IBD至关重要.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
264
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
264
Gap Junctions
8.0K
The cytoplasm of adjacent animal cells can exchange small molecules, ions, and secondary messengers via the communication channels which form the gap junctions. These junctions comprise a few hundred to thousands of molecular channels, each made of two halves, called the connexon hemichannel. A connexon is a hexamer of six transmembrane connexin proteins, which assemble radially, thus forming a pore or channel in the center. One connexon hemichannel docks with a corresponding connexon on the...
8.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
150
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
150
Inflammatory Bowel Disease I: Ulcerative Colitis
196
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
196
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
339
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
339
Inflammatory Bowel Disease IV: Pharmacological Management
135
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
135

